🇺🇸 FDA
Patent

US 11220479

Glucosylceramide synthase inhibitors and therapeutic methods using the same

granted A61PA61P13/12A61P25/00

Quick answer

US patent 11220479 (Glucosylceramide synthase inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P13/12, A61P25/00, A61P25/16, A61P3/10